Evidence map›Paper›PMID 41148637›Full record

ArticleInfectious disease reports2025

Dolutegravir Resistance in Mozambique: Insights from a Programmatic HIV Resistance Testing Intervention in a Highly Antiretroviral Therapy-Experienced Cohort.

Maria Ruano, Antonio Flores, Aleny Couto, Irénio Gaspar, Sabine Yerly, Ana Gabriela Gutierrez Zamudio, Rosa Bene, Adelina Maiela, Helder Macuacua, Jeff Lane and 2 more

Abstract read
In one paragraph

Article in Infectious disease reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maria RuanoI-TECH Mozambique "International Training & Education Center for Health", Bairro Sommerschield, Avenue Cahora Bassa N# 106, Maputo P.O. Box 1102, Mozambique.
Antonio FloresSouthern Africa Medical Unit, Médecins Sans Frontières, Cape Town P.O. Box 7925, South Africa.ORCID 0009-0007-8488-4745
Aleny CoutoNational STI/HIV/AIDS Program, Ministry of Health, Maputo P.O. Box 264, Mozambique.
Irénio GasparNational STI/HIV/AIDS Program, Ministry of Health, Maputo P.O. Box 264, Mozambique.
Sabine YerlyVirology Laboratory, Hôpitaux Universitaires de Genève, P.O. Box 1205, 1211 Geneva, Switzerland.
Ana Gabriela Gutierrez ZamudioMédecins Sans Frontières, Maputo P.O. Box 1224, Mozambique.
Rosa BeneI-TECH Mozambique "International Training & Education Center for Health", Bairro Sommerschield, Avenue Cahora Bassa N# 106, Maputo P.O. Box 1102, Mozambique.
Adelina MaielaI-TECH Mozambique "International Training & Education Center for Health", Bairro Sommerschield, Avenue Cahora Bassa N# 106, Maputo P.O. Box 1102, Mozambique.
Helder MacuacuaI-TECH Mozambique "International Training & Education Center for Health", Bairro Sommerschield, Avenue Cahora Bassa N# 106, Maputo P.O. Box 1102, Mozambique.
Jeff LaneDepartment of Global Health, University of Washington, 908 Jefferson St., 12th Floor, Seattle, WA 98195, USA.ORCID 0000-0001-7001-1010
Florindo MudenderI-TECH Mozambique "International Training & Education Center for Health", Bairro Sommerschield, Avenue Cahora Bassa N# 106, Maputo P.O. Box 1102, Mozambique.
Edy NacarapaI-TECH Mozambique "International Training & Education Center for Health", Bairro Sommerschield, Avenue Cahora Bassa N# 106, Maputo P.O. Box 1102, Mozambique.ORCID 0000-0002-0617-9609

Funding

CDC HHS NU2GGH002374Médecins Sans Frontières HIVDR-Moz-CRAM
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dolutegravirHIV genotypic resistance testingHIV resistanceMozambiquePLWH

Identifiers

PMID41148637
PMCPMC12562945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.